In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

MedTech Forum 2019: The Future Is Here But Industry Still Needs A Long-Term Vision

By Ashley Yeo 16 Aug 2019

In a world where national economies are beset by conflicting spending priorities, health care is oftentimes too low on the agenda, health care observers say. One of these is Boston Scientific senior vice-president Eric Thépaut, who understands the dilemmas, but says that health care will soon force its way up the priority list. He has advice for future-ready medtech innovators.

Generics Bulletin

Hikma Snaps Up Insys Sprays As Part Of US Drive Towards Differentiation

15 Aug 2019

By acquiring global rights to epinephrine and naloxone nasal spray candidates from Insys, Hikma is following its strategy of moving its non-injectable Generics business segment in the US towards differentiated products.

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

The Chinese Pharma Market: Insights in turbulent times

12 Aug 2019

With the continuation of the US-China trade standoff, the rapid increase in R&D costs and a gruelling centralized bidding process, foreign pharma firms have a lot on their plates in China. Gain insight on these key challenges through this Scrip article pack

Reddy's Will Look For Acquisitions Under New CEO Israeli

09 Aug 2019

With Erez Israeli set to step up from COO to CEO, Dr Reddy’s is looking to leverage its lack of debt and strong cash flow in the mergers and acquisitions arena.

Medtech Insight: 世界の医療機器・医療技術の最新情報

Exact Sciences Buys Genomic Health In $2.8Bn Expansion Deal

06 Aug 2019

Cancer diagnostics company Exact Sciences is combining with Genomic Health in a major merger valued at $2.8bn. The combined company will offer two of the fastest growing brands in cancer diagnostics, Cologuard and Oncotype DX.

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Love From Shanghai: Upjohn Started Here But Will It Stay Post-Mylan?

By Brian Yang 05 Aug 2019

Opened with a big splash just two months ago in a brand new headquarters in Shanghai, Pfizer's Upjohn established products subsidiary is now merging with Mylan to create the world's largest generics group, stirring up local concerns that the focus could shift from China back to the US.

Meddevicetracker: 医療機器の市場調査分析・データベース

Introducing Meddevicetracker's Market Analysis Tool

02 Aug 2019

Find and manipulate the essential medical devices and diagnostics market intelligence you rely on from Meddevicetracker’s Market Analysis Reports with Meddevicetracker’s new interactive Market Analysis tool. 

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Medicare Price Inflation Rebates, Part D ‘Redesign’ Proposed In Senate Finance Bill

26 Jul 2019

Price inflation rebates are expected to generate $50bn in savings over 10 years, according to the Congressional Budget Office.